Preclinical CROs in China

16 contract research organizations in our directory list a site in China. 8 report GLP capability and 5 report AAALAC accreditation. Compare services, species and accreditations below, and contact labs directly from their profiles.

16 CROs 8 GLP 5 AAALAC

Preclinical research in China

China has grown into one of the largest centers of preclinical capacity, with integrated discovery providers and large toxicology facilities offering rodent, dog and nonhuman primate studies, often with competitive timelines and pricing.

Laboratories are certified for GLP by China’s National Medical Products Administration (NMPA). China is not a full adherent to the OECD Mutual Acceptance of Data system, so for studies intended to support a US or EU filing, ask about the facility’s FDA or OECD-country inspection history and how the data will be presented to your regulator.

Among the CROs listed in China, the most common services are In Vivo Efficacy, Pharmacokinetics, Toxicology and Bioanalysis. The species they most often work with are Mouse, Non-human Primate and Rat.

Preclinical CROs in China

Showing 16 CROs with a site in China. Order rotates daily so no lab is permanently listed first.

JOINN Laboratories

Beijing GLP

Large China-based nonclinical CRO offering GLP safety assessment, pharmacology, pharmacokinetics and bioanalysis, with operations in China and the United States.

Bioanalysis GLP Toxicology In Vivo Efficacy Pharmacokinetics Repeat-Dose Toxicity Cynomolgus monkey Dog Non-human Primate Rat

Shanghai LIDE Biotech

Shanghai

Shanghai oncology CRO with patient-derived xenograft and other tumor models for efficacy studies.

In Vivo Efficacy Oncology Models PDX Models Mouse

Medicilon

Shanghai GLP AAALAC
Bioanalysis Toxicology Dog Mouse Non-human Primate Rabbit

Shanghai Model Organisms Center (SMOC)

Shanghai

Shanghai provider of genetically engineered rodent models with phenotyping and in vivo pharmacology services.

In Vivo Efficacy Metabolic Disease Models Oncology Models Mouse Rat

InnoStar

Shanghai GLP AAALAC

Shanghai-based nonclinical CRO with GLP safety evaluation, pharmacology, DMPK, bioanalysis and biomarker services for small molecules, biologics and cell and gene therapies, operating several sites in China.

Bioanalysis Biomarker Analysis Cell Therapy Gene Therapy Studies GLP Toxicology Dog Mouse Non-human Primate Rat

Kunming Biomed International (KBI)

Kunming AAALAC

Southwest China pharmacology CRO specializing in nonhuman primate efficacy, PK/PD and exploratory safety studies.

In Vivo Efficacy Pharmacokinetics Toxicology Non-human Primate

Prisys Biotechnologies

Shanghai GLP

Shanghai CRO centered on nonhuman primate efficacy and safety studies, with NHP disease models across metabolism, cardiovascular, renal, neurology and ophthalmology, clinical-style imaging and interventional surgery.

In Vivo Efficacy In Vivo Imaging MRI Studies PET Imaging Surgical Models Cynomolgus monkey Non-human Primate

Biocytogen

Beijing

Beijing-based company providing genetically engineered and humanized mouse models with in vivo pharmacology services, especially for oncology and immunology antibody programs.

Antibody Programs In Vivo Efficacy Oncology Models Syngeneic Models Xenograft Models Mouse

WuXi AppTec

CN Verified GLP AAALAC

Global R&D services including discovery, DMPK, toxicology, bioanalysis, and manufacturing support.

Bioanalysis Histology Pharmacokinetics Surgery Toxicology Cynomolgus monkey Dog Mouse Pig

GemPharmatech

Nanjing

Chinese provider of genetically engineered mouse models with in vivo pharmacology services across oncology, immunology and metabolic disease.

In Vivo Efficacy Metabolic Disease Models Oncology Models PDX Models Mouse

PharmaLegacy Laboratories

Shanghai GLP AAALAC

Preclinical pharmacology CRO in Shanghai with specialty efficacy models in autoimmunity, inflammation, bone and orthopedics, oncology and metabolic disease, plus supporting PK/PD and exploratory toxicology.

Bone & Joint Models In Vivo Efficacy Inflammation Models Metabolic Disease Models Oncology Models Dog Mouse Non-human Primate Rabbit

SAFE Pharma (Beijing Saifu)

Beijing GLP

Beijing-based preclinical CRO focused on GLP safety evaluation, with branches across China and support for biologics, nucleic acid and cell and gene therapies.

Gene Therapy Studies GLP Toxicology Pharmacokinetics Safety Pharmacology Dog Non-human Primate Rat

Hubei Topgene Biotechnology

Wuhan GLP

Wuhan CRO integrating NHP breeding with toxicity and safety evaluation, PK/PD, molecular imaging and bioanalysis.

Bioanalysis In Vivo Imaging Pharmacokinetics Toxicology Non-human Primate

Questions to ask a CRO in China

  • Will the study run at the site in China, or could work be moved to another of your facilities?
  • How do you receive test article shipments, and what import permits or customs paperwork do you handle?
  • Can our team visit the facility before the study starts and during critical phases?
  • Which regulators and GLP monitoring authorities have inspected this site, and when?
  • What is your current lead time for our species at this site?

For a full checklist, see our CRO selection guide.